META's IP Portfolio Surpasses its 200 Patent Goal for 2021 with a Total of 247 Patents

HALIFAX, NS / ACCESSWIRE / November 4, 2021 / Meta Materials Inc. (the "Company" or "META®") (NASDAQ:MMAT)(FSE:MMAT) a developer of high-performance functional materials and nanocomposites, today announced that the Company has far exceeded its goal of reaching 200 patents in 2021. Including the patents added with the Nanotech acquisition, META now has a total of 247 patents (154 issued patents and 93 pending applications, including three design applications) in 65 patent families, of which 44 families include at least one issued patent. The total number of patents has increased by 166% vs. 93 at Y.E. 2020, and the number of patent families has more than doubled compared to 28 last year. The portfolio comprises 34 issued patents and 21 pending applications in the U.S., and 120 issued patents and 72 pending applications in 23 countries around the world.

"These additions to our IP portfolio highlight META's strong commitment to innovation in the field of high-performance functional materials and nanocomposites, and the importance of protecting and maintaining the quality of our disruptive technological achievements. We will continue to pursue strong and broad protection for our innovations and anticipate the filing of at least 30 patent applications in 2022," said Shann Kerner, META's Chief Intellectual Property Officer.

The Nanotech acquisition contributed 19 patent families, of which 16 families include at least one granted patent. The newly added patent families cover document authentication, nanofabrication (including e-beam and nanoimprint lithography processes), scaled roll-to-roll manufacturing systems, as well as plasmonic, diffractive and photonic crystal nanostructures. META's patent families cover a wide range of technologies and applications, including but not limited to large-area holographic filtering, scanning holography, light capture for solar panels, large-area nanopatterning, near-field lithography, plasmonic lithography, transparent metal meshes, radio wave imaging, non-invasive glucose sensing, and magnetic resonance imaging. META's IP supports and protects the Company's development work in a wide range of markets, including consumer electronics, augmented reality, solar energy and lighting, automotive, aerospace, medical imaging, sensing and communications.

"META is a platform company developing sustainable and disruptive technologies and products in the rapidly growing field of high-performance functional materials. We are committed to aggressively growing and defending our patent estate to protect our leadership position, to take full advantage of the commercial opportunities our patents provide for our innovations, and to continue to develop our brands and trademarks," said Kenneth Rice, META's Chief Financial Officer and EVP.

About Meta Materials Inc.

META® delivers previously unachievable performance, across a range of applications, by inventing, designing, developing, and manufacturing sustainable, highly functional materials. Our extensive technology platform enables leading global brands to deliver breakthrough products to their customers in consumer electronics, 5G communications, health and wellness, aerospace, automotive, and clean energy. Our nano-optic technology provides anti-counterfeiting security features for government documents and currencies and authentication for brands. Our achievements have been widely recognized, including being named a Lux Research Innovator of the Year in 2021. Learn more at www.metamaterial.com.

Forward Looking Information

This press release includes forward-looking information or statements within the meaning of Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, regarding the Company, Nanotech, their businesses and the transaction, which may include, but are not limited to, statements with respect to the business strategies, product development, expansion plans and operational activities of the Company and Nanotech, production capacity expansion, the benefits to the Company of the acquisition of Nanotech and the benefits of nanotechnology to the Company's partners and within the industries in which they operate. Often but not always, forward-looking information can be identified by the use of words such as "potential," "predicts," "projects," "seeks," "plans," "expect", "intends", "anticipated", "believes", "developing", "focused", "extending", "position" or variations (including negative variations) of such words and phrases, or statements that certain actions, events or results "may", "could", "should," "can", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although the management of the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks related to the potential benefits of the transaction with Nanotech, the capabilities of Nanotech's facility and the expansion thereof, research and development projects of the Company, the market potential of the products of the Company and Nanotech, the market position of the Company, the scalability of the Company's production ability, capacity for new customer engagements, material selection programs timeframes, the ability to reduce production costs, enhance metamaterials manufacturing capabilities and extend market reach into new applications and industries, the ability to accelerate commercialization plans, the possibility of new customer contracts, the continued engagement of Nanotech's team, the technology industry, market strategic and operational activities, and management's ability to manage and to operate the business. More details about these and other risks that may impact the Company's businesses are described under the heading "Forward Looking Statement" in the Company's Form 8-K filed with the SEC on August 10, 2021, and under the heading "Risk Factors" in the Company's Form 10-Q filed with the SEC on August 13, 2021, in the Company's Form 10-K filed with the SEC on March 18, 2021, and in subsequent filings made by Meta Materials with the SEC, which are available on SEC's website at www.sec.gov. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward looking statement, whether as a result of new information, future events, or otherwise, except to the extent required by law.

Contact

Mark Komonoski
Senior Vice President
Integrous Communications
Phone: 1-877-255-8483
Email: ir@metamaterial.com

Media inquiries

Rob Stone
Vice President, Corporate Development and Communications
Meta Materials Inc.
media@metamaterial.com

SOURCE: Meta Materials Inc.



View source version on accesswire.com:
https://www.accesswire.com/671157/METAs-IP-Portfolio-Surpasses-its-200-Patent-Goal-for-2021-with-a-Total-of-247-Patents

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.